Vision-Sciences' EndoSheath Technology offers patented solution to 'nightmare bacteria'

By Healthcare Facilities Today


ORANGEBURG, N.Y. - An outbreak of "Nightmare Bacteria," also known as the "Super Bug," has raised new alarm bells in the healthcare industry over patient safety. The concern stems from 44 newly reported cases of cross-contamination infections as a result of endoscopic procedures done at Advocate Lutheran General Hospital, located just outside of Chicago.

"This type of outbreak not only undermines patient confidence, it creates stiff potential financial liabilities for hospitals and other healthcare facilities under the Affordable Care Act," said Howard Zauberman, President and Chief Executive Officer of Vision-Sciences, Inc. (Nasdaq:VSCI) -- a company specializing in endoscopes that help safeguard patients from cross-contamination infections caused by conventional endoscopes.

Vision-Sciences (www.visionsciences.com) provides patented technology solutions that safeguard patients with a sterile cover, or EndoSheath(R) Technology, for its endoscopes. This prevents direct contact of the scope with the patient and reduces the risk of contracting infections from bacteria such as the Nightmare Bacteria as a result of endoscopic cross-contamination. In 20 years and with over 5 million procedures performed with EndoSheath(R) Technology, Vision-Sciences has never received a report of cross-contamination.

"We feel confident that our EndoSheath(R) Technology is a win-win for  the healthcare facility and its patients. It is in our best interest to ensure that all healthcare professionals are aware of this alternative to conventional endoscopes while offering a cost cutting and liability reducing solution," said Lewis C. Pell, Chairman and Co-founder of Vision-Sciences.

About Vision-Sciences, Inc.

Vision-Sciences, Inc. designs, develops, manufactures and markets products for flexible endoscopy. The Company's unique product lines feature a streamlined visualization system and proprietary sterile disposable microbial barrier, known as EndoSheath(R) technology, providing users with efficient and cost effective endoscope turnover while enhancing patient safety. Information about Vision-Sciences' products is available at www.visionsciences.com.

Vision-Sciences owns the trademarks Vision Sciences(TM) and Slide-On(TM) and the registered trademarks EndoSheath(R), EndoWipe(R) and The Vision System(R).



January 15, 2014


Topic Area: Press Release


Recent Posts

Healthcare Real Estate: Challenges and Industry Shifts for 2025

The hurdles include balancing expansion with financial constraints, the sustainability of office and retail conversions, and technological disruptions.


Geisinger to Build $32 Million Cancer Center in Pennsylvania

The two-story, 40,000-square-foot facility will be home to the cancer center with space for future growth of services.


Sunflower Medical Group Experiences Data Breach

To date, Sunflower has no evidence that personal information has been misused.


Strategies to Eradicate Biofilm Containing C. Auris

Understanding the speed and risks of contamination after room disinfection should inform managers’ environmental cleaning recommendations.


Man Attacks Nurses, Police Officer at Jefferson Hospital

The man allegedly attacked the staff members before being restrained and sedated.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.